FDA accepts Cogent Biosciences NDA for bezuclastinib in AdvSM
Cogent Biosciences, Inc. (Nasdaq: COGT) announced that the U.S. Food and Drug Administration has accepted its New Drug Application for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
